nodes	percent_of_prediction	percent_of_DWPC	metapath
Gonadorelin—Pentagastrin—BCHE—kidney cancer	0.0118	0.61	CrCbGaD
Gonadorelin—Thromboembolism—Doxorubicin—kidney cancer	0.00834	0.0085	CcSEcCtD
Gonadorelin—Embolism—Paclitaxel—kidney cancer	0.00781	0.00796	CcSEcCtD
Gonadorelin—Redness—Paclitaxel—kidney cancer	0.00742	0.00757	CcSEcCtD
Gonadorelin—Breast disorder—Pazopanib—kidney cancer	0.00742	0.00757	CcSEcCtD
Gonadorelin—Upper respiratory tract infection—Temsirolimus—kidney cancer	0.007	0.00714	CcSEcCtD
Gonadorelin—Haematoma—Capecitabine—kidney cancer	0.00654	0.00667	CcSEcCtD
Gonadorelin—Embolism—Capecitabine—kidney cancer	0.00641	0.00653	CcSEcCtD
Gonadorelin—Injection site reaction—Gemcitabine—kidney cancer	0.00595	0.00607	CcSEcCtD
Gonadorelin—Breast disorder—Everolimus—kidney cancer	0.00586	0.00597	CcSEcCtD
Gonadorelin—Breast pain—Paclitaxel—kidney cancer	0.00574	0.00586	CcSEcCtD
Gonadorelin—Contusion—Paclitaxel—kidney cancer	0.00574	0.00586	CcSEcCtD
Gonadorelin—Angiopathy—Temsirolimus—kidney cancer	0.00547	0.00558	CcSEcCtD
Gonadorelin—Immune system disorder—Temsirolimus—kidney cancer	0.00545	0.00555	CcSEcCtD
Gonadorelin—Embolism venous—Doxorubicin—kidney cancer	0.00525	0.00536	CcSEcCtD
Gonadorelin—Erythema—Temsirolimus—kidney cancer	0.00525	0.00535	CcSEcCtD
Gonadorelin—Upper respiratory tract infection—Everolimus—kidney cancer	0.00521	0.00531	CcSEcCtD
Gonadorelin—Angiopathy—Pazopanib—kidney cancer	0.00515	0.00526	CcSEcCtD
Gonadorelin—Breast disorder—Sorafenib—kidney cancer	0.00509	0.00519	CcSEcCtD
Gonadorelin—Injection site reaction—Paclitaxel—kidney cancer	0.00498	0.00508	CcSEcCtD
Gonadorelin—Erythema—Pazopanib—kidney cancer	0.00494	0.00504	CcSEcCtD
Gonadorelin—Flatulence—Pazopanib—kidney cancer	0.00487	0.00497	CcSEcCtD
Gonadorelin—Desmopressin—PTGS1—kidney cancer	0.00481	0.248	CrCbGaD
Gonadorelin—Contusion—Capecitabine—kidney cancer	0.00471	0.00481	CcSEcCtD
Gonadorelin—Abdominal discomfort—Sorafenib—kidney cancer	0.00466	0.00475	CcSEcCtD
Gonadorelin—Abdominal discomfort—Sunitinib—kidney cancer	0.00449	0.00458	CcSEcCtD
Gonadorelin—Pelvic pain—Doxorubicin—kidney cancer	0.00436	0.00444	CcSEcCtD
Gonadorelin—Upper respiratory tract infection—Sunitinib—kidney cancer	0.00435	0.00444	CcSEcCtD
Gonadorelin—Anaphylactic shock—Temsirolimus—kidney cancer	0.00428	0.00437	CcSEcCtD
Gonadorelin—Nervous system disorder—Temsirolimus—kidney cancer	0.0042	0.00428	CcSEcCtD
Gonadorelin—Embolism—Doxorubicin—kidney cancer	0.00413	0.00421	CcSEcCtD
Gonadorelin—Swelling—Paclitaxel—kidney cancer	0.00412	0.0042	CcSEcCtD
Gonadorelin—Injection site reaction—Capecitabine—kidney cancer	0.00409	0.00417	CcSEcCtD
Gonadorelin—Angiopathy—Everolimus—kidney cancer	0.00407	0.00415	CcSEcCtD
Gonadorelin—Immune system disorder—Everolimus—kidney cancer	0.00405	0.00413	CcSEcCtD
Gonadorelin—Shock—Pazopanib—kidney cancer	0.00397	0.00405	CcSEcCtD
Gonadorelin—Nervous system disorder—Pazopanib—kidney cancer	0.00396	0.00404	CcSEcCtD
Gonadorelin—Redness—Doxorubicin—kidney cancer	0.00393	0.004	CcSEcCtD
Gonadorelin—Erythema—Everolimus—kidney cancer	0.0039	0.00398	CcSEcCtD
Gonadorelin—Flatulence—Everolimus—kidney cancer	0.00385	0.00392	CcSEcCtD
Gonadorelin—Erythema—Erlotinib—kidney cancer	0.00377	0.00384	CcSEcCtD
Gonadorelin—Flatulence—Erlotinib—kidney cancer	0.00371	0.00379	CcSEcCtD
Gonadorelin—Gastrointestinal disorder—Temsirolimus—kidney cancer	0.0037	0.00377	CcSEcCtD
Gonadorelin—Fatigue—Temsirolimus—kidney cancer	0.00369	0.00377	CcSEcCtD
Gonadorelin—Pain—Temsirolimus—kidney cancer	0.00366	0.00374	CcSEcCtD
Gonadorelin—Constipation—Temsirolimus—kidney cancer	0.00366	0.00374	CcSEcCtD
Gonadorelin—Angiopathy—Sorafenib—kidney cancer	0.00353	0.0036	CcSEcCtD
Gonadorelin—Immune system disorder—Sorafenib—kidney cancer	0.00352	0.00359	CcSEcCtD
Gonadorelin—Gastrointestinal pain—Temsirolimus—kidney cancer	0.0035	0.00357	CcSEcCtD
Gonadorelin—Gastrointestinal disorder—Pazopanib—kidney cancer	0.00348	0.00355	CcSEcCtD
Gonadorelin—Fatigue—Pazopanib—kidney cancer	0.00348	0.00355	CcSEcCtD
Gonadorelin—Pain—Pazopanib—kidney cancer	0.00345	0.00352	CcSEcCtD
Gonadorelin—Angiopathy—Sunitinib—kidney cancer	0.0034	0.00347	CcSEcCtD
Gonadorelin—Erythema—Sorafenib—kidney cancer	0.00339	0.00346	CcSEcCtD
Gonadorelin—Abdominal pain—Temsirolimus—kidney cancer	0.00339	0.00345	CcSEcCtD
Gonadorelin—Swelling—Capecitabine—kidney cancer	0.00338	0.00345	CcSEcCtD
Gonadorelin—Immune system disorder—Sunitinib—kidney cancer	0.00338	0.00345	CcSEcCtD
Gonadorelin—Gastrointestinal pain—Pazopanib—kidney cancer	0.0033	0.00336	CcSEcCtD
Gonadorelin—Breast disorder—Paclitaxel—kidney cancer	0.00329	0.00335	CcSEcCtD
Gonadorelin—Erythema—Sunitinib—kidney cancer	0.00326	0.00333	CcSEcCtD
Gonadorelin—Flatulence—Sunitinib—kidney cancer	0.00321	0.00328	CcSEcCtD
Gonadorelin—Abdominal pain—Pazopanib—kidney cancer	0.00319	0.00325	CcSEcCtD
Gonadorelin—Hypersensitivity—Temsirolimus—kidney cancer	0.00316	0.00322	CcSEcCtD
Gonadorelin—Shock—Everolimus—kidney cancer	0.00313	0.0032	CcSEcCtD
Gonadorelin—Nervous system disorder—Everolimus—kidney cancer	0.00312	0.00319	CcSEcCtD
Gonadorelin—Erythema—Dactinomycin—kidney cancer	0.00309	0.00315	CcSEcCtD
Gonadorelin—Asthenia—Temsirolimus—kidney cancer	0.00307	0.00313	CcSEcCtD
Gonadorelin—Breast pain—Doxorubicin—kidney cancer	0.00304	0.0031	CcSEcCtD
Gonadorelin—Pruritus—Temsirolimus—kidney cancer	0.00303	0.00309	CcSEcCtD
Gonadorelin—Shock—Erlotinib—kidney cancer	0.00302	0.00308	CcSEcCtD
Gonadorelin—Nervous system disorder—Erlotinib—kidney cancer	0.00301	0.00307	CcSEcCtD
Gonadorelin—Diarrhoea—Temsirolimus—kidney cancer	0.00293	0.00299	CcSEcCtD
Gonadorelin—Upper respiratory tract infection—Paclitaxel—kidney cancer	0.00292	0.00298	CcSEcCtD
Gonadorelin—Asthenia—Pazopanib—kidney cancer	0.0029	0.00295	CcSEcCtD
Gonadorelin—Angiopathy—Vincristine—kidney cancer	0.00287	0.00293	CcSEcCtD
Gonadorelin—Pruritus—Pazopanib—kidney cancer	0.00286	0.00291	CcSEcCtD
Gonadorelin—Anaphylactic shock—Sorafenib—kidney cancer	0.00277	0.00282	CcSEcCtD
Gonadorelin—Diarrhoea—Pazopanib—kidney cancer	0.00276	0.00282	CcSEcCtD
Gonadorelin—Gastrointestinal disorder—Everolimus—kidney cancer	0.00275	0.00281	CcSEcCtD
Gonadorelin—Desmopressin—PTGS2—kidney cancer	0.00275	0.142	CrCbGaD
Gonadorelin—Fatigue—Everolimus—kidney cancer	0.00275	0.0028	CcSEcCtD
Gonadorelin—Constipation—Vinblastine—kidney cancer	0.00274	0.00279	CcSEcCtD
Gonadorelin—Pain—Vinblastine—kidney cancer	0.00274	0.00279	CcSEcCtD
Gonadorelin—Angiopathy—Gemcitabine—kidney cancer	0.00273	0.00278	CcSEcCtD
Gonadorelin—Pain—Everolimus—kidney cancer	0.00272	0.00278	CcSEcCtD
Gonadorelin—Constipation—Everolimus—kidney cancer	0.00272	0.00278	CcSEcCtD
Gonadorelin—Vomiting—Temsirolimus—kidney cancer	0.00272	0.00278	CcSEcCtD
Gonadorelin—Shock—Sorafenib—kidney cancer	0.00272	0.00277	CcSEcCtD
Gonadorelin—Immune system disorder—Gemcitabine—kidney cancer	0.00271	0.00277	CcSEcCtD
Gonadorelin—Nervous system disorder—Sorafenib—kidney cancer	0.00271	0.00277	CcSEcCtD
Gonadorelin—Breast disorder—Capecitabine—kidney cancer	0.0027	0.00275	CcSEcCtD
Gonadorelin—Headache—Temsirolimus—kidney cancer	0.00268	0.00274	CcSEcCtD
Gonadorelin—Gastrointestinal disorder—Erlotinib—kidney cancer	0.00265	0.00271	CcSEcCtD
Gonadorelin—Fatigue—Erlotinib—kidney cancer	0.00265	0.0027	CcSEcCtD
Gonadorelin—Injection site reaction—Doxorubicin—kidney cancer	0.00264	0.00269	CcSEcCtD
Gonadorelin—Pain—Erlotinib—kidney cancer	0.00263	0.00268	CcSEcCtD
Gonadorelin—Constipation—Erlotinib—kidney cancer	0.00263	0.00268	CcSEcCtD
Gonadorelin—Shock—Sunitinib—kidney cancer	0.00262	0.00267	CcSEcCtD
Gonadorelin—Erythema—Gemcitabine—kidney cancer	0.00262	0.00267	CcSEcCtD
Gonadorelin—Gastrointestinal pain—Vinblastine—kidney cancer	0.00262	0.00267	CcSEcCtD
Gonadorelin—Nervous system disorder—Sunitinib—kidney cancer	0.00261	0.00266	CcSEcCtD
Gonadorelin—Gastrointestinal pain—Everolimus—kidney cancer	0.00261	0.00266	CcSEcCtD
Gonadorelin—Vomiting—Pazopanib—kidney cancer	0.00257	0.00262	CcSEcCtD
Gonadorelin—Nausea—Temsirolimus—kidney cancer	0.00254	0.00259	CcSEcCtD
Gonadorelin—Abdominal pain—Vinblastine—kidney cancer	0.00253	0.00258	CcSEcCtD
Gonadorelin—Headache—Pazopanib—kidney cancer	0.00253	0.00258	CcSEcCtD
Gonadorelin—Abdominal pain—Everolimus—kidney cancer	0.00252	0.00257	CcSEcCtD
Gonadorelin—Gastrointestinal pain—Erlotinib—kidney cancer	0.00251	0.00256	CcSEcCtD
Gonadorelin—Abdominal discomfort—Capecitabine—kidney cancer	0.00247	0.00252	CcSEcCtD
Gonadorelin—Abdominal pain—Erlotinib—kidney cancer	0.00243	0.00248	CcSEcCtD
Gonadorelin—Upper respiratory tract infection—Capecitabine—kidney cancer	0.0024	0.00245	CcSEcCtD
Gonadorelin—Nausea—Pazopanib—kidney cancer	0.0024	0.00244	CcSEcCtD
Gonadorelin—Gastrointestinal disorder—Sorafenib—kidney cancer	0.00239	0.00243	CcSEcCtD
Gonadorelin—Fatigue—Sorafenib—kidney cancer	0.00238	0.00243	CcSEcCtD
Gonadorelin—Pain—Sorafenib—kidney cancer	0.00237	0.00241	CcSEcCtD
Gonadorelin—Constipation—Sorafenib—kidney cancer	0.00237	0.00241	CcSEcCtD
Gonadorelin—Hypersensitivity—Vinblastine—kidney cancer	0.00236	0.0024	CcSEcCtD
Gonadorelin—Hypersensitivity—Everolimus—kidney cancer	0.00235	0.00239	CcSEcCtD
Gonadorelin—Gastrointestinal disorder—Sunitinib—kidney cancer	0.0023	0.00234	CcSEcCtD
Gonadorelin—Asthenia—Vinblastine—kidney cancer	0.00229	0.00234	CcSEcCtD
Gonadorelin—Fatigue—Sunitinib—kidney cancer	0.00229	0.00234	CcSEcCtD
Gonadorelin—Asthenia—Everolimus—kidney cancer	0.00229	0.00233	CcSEcCtD
Gonadorelin—Angiopathy—Paclitaxel—kidney cancer	0.00228	0.00233	CcSEcCtD
Gonadorelin—Pain—Sunitinib—kidney cancer	0.00228	0.00232	CcSEcCtD
Gonadorelin—Constipation—Sunitinib—kidney cancer	0.00228	0.00232	CcSEcCtD
Gonadorelin—Immune system disorder—Paclitaxel—kidney cancer	0.00227	0.00232	CcSEcCtD
Gonadorelin—Gastrointestinal pain—Sorafenib—kidney cancer	0.00226	0.00231	CcSEcCtD
Gonadorelin—Pruritus—Everolimus—kidney cancer	0.00225	0.0023	CcSEcCtD
Gonadorelin—Anaphylactic shock—Vincristine—kidney cancer	0.00225	0.0023	CcSEcCtD
Gonadorelin—Nervous system disorder—Vincristine—kidney cancer	0.00221	0.00225	CcSEcCtD
Gonadorelin—Asthenia—Erlotinib—kidney cancer	0.00221	0.00225	CcSEcCtD
Gonadorelin—Erythema—Paclitaxel—kidney cancer	0.00219	0.00223	CcSEcCtD
Gonadorelin—Diarrhoea—Vinblastine—kidney cancer	0.00219	0.00223	CcSEcCtD
Gonadorelin—Abdominal pain—Sorafenib—kidney cancer	0.00219	0.00223	CcSEcCtD
Gonadorelin—Diarrhoea—Everolimus—kidney cancer	0.00218	0.00222	CcSEcCtD
Gonadorelin—Gastrointestinal pain—Sunitinib—kidney cancer	0.00218	0.00222	CcSEcCtD
Gonadorelin—Pruritus—Erlotinib—kidney cancer	0.00218	0.00222	CcSEcCtD
Gonadorelin—Fatigue—Dactinomycin—kidney cancer	0.00217	0.00222	CcSEcCtD
Gonadorelin—Flatulence—Paclitaxel—kidney cancer	0.00216	0.0022	CcSEcCtD
Gonadorelin—Pain—Dactinomycin—kidney cancer	0.00215	0.0022	CcSEcCtD
Gonadorelin—Anaphylactic shock—Gemcitabine—kidney cancer	0.00214	0.00218	CcSEcCtD
Gonadorelin—Abdominal pain—Sunitinib—kidney cancer	0.0021	0.00215	CcSEcCtD
Gonadorelin—Diarrhoea—Erlotinib—kidney cancer	0.0021	0.00214	CcSEcCtD
Gonadorelin—Nervous system disorder—Gemcitabine—kidney cancer	0.00209	0.00214	CcSEcCtD
Gonadorelin—Gastrointestinal pain—Dactinomycin—kidney cancer	0.00206	0.0021	CcSEcCtD
Gonadorelin—Hypersensitivity—Sorafenib—kidney cancer	0.00204	0.00208	CcSEcCtD
Gonadorelin—Vomiting—Vinblastine—kidney cancer	0.00203	0.00207	CcSEcCtD
Gonadorelin—Vomiting—Everolimus—kidney cancer	0.00203	0.00207	CcSEcCtD
Gonadorelin—Headache—Vinblastine—kidney cancer	0.002	0.00204	CcSEcCtD
Gonadorelin—Headache—Everolimus—kidney cancer	0.002	0.00204	CcSEcCtD
Gonadorelin—Abdominal pain—Dactinomycin—kidney cancer	0.00199	0.00203	CcSEcCtD
Gonadorelin—Asthenia—Sorafenib—kidney cancer	0.00198	0.00202	CcSEcCtD
Gonadorelin—Hypersensitivity—Sunitinib—kidney cancer	0.00196	0.002	CcSEcCtD
Gonadorelin—Pruritus—Sorafenib—kidney cancer	0.00196	0.002	CcSEcCtD
Gonadorelin—Vomiting—Erlotinib—kidney cancer	0.00195	0.00199	CcSEcCtD
Gonadorelin—Gastrointestinal disorder—Vincristine—kidney cancer	0.00194	0.00198	CcSEcCtD
Gonadorelin—Fatigue—Vincristine—kidney cancer	0.00194	0.00198	CcSEcCtD
Gonadorelin—Headache—Erlotinib—kidney cancer	0.00193	0.00196	CcSEcCtD
Gonadorelin—Pain—Vincristine—kidney cancer	0.00192	0.00196	CcSEcCtD
Gonadorelin—Constipation—Vincristine—kidney cancer	0.00192	0.00196	CcSEcCtD
Gonadorelin—Asthenia—Sunitinib—kidney cancer	0.00191	0.00195	CcSEcCtD
Gonadorelin—Nausea—Vinblastine—kidney cancer	0.0019	0.00194	CcSEcCtD
Gonadorelin—Nausea—Everolimus—kidney cancer	0.00189	0.00193	CcSEcCtD
Gonadorelin—Diarrhoea—Sorafenib—kidney cancer	0.00189	0.00193	CcSEcCtD
Gonadorelin—Pruritus—Sunitinib—kidney cancer	0.00188	0.00192	CcSEcCtD
Gonadorelin—Angiopathy—Capecitabine—kidney cancer	0.00187	0.00191	CcSEcCtD
Gonadorelin—Immune system disorder—Capecitabine—kidney cancer	0.00187	0.0019	CcSEcCtD
Gonadorelin—Hypersensitivity—Dactinomycin—kidney cancer	0.00186	0.00189	CcSEcCtD
Gonadorelin—Gastrointestinal disorder—Gemcitabine—kidney cancer	0.00184	0.00188	CcSEcCtD
Gonadorelin—Fatigue—Gemcitabine—kidney cancer	0.00184	0.00188	CcSEcCtD
Gonadorelin—Gastrointestinal pain—Vincristine—kidney cancer	0.00184	0.00188	CcSEcCtD
Gonadorelin—Constipation—Gemcitabine—kidney cancer	0.00183	0.00186	CcSEcCtD
Gonadorelin—Pain—Gemcitabine—kidney cancer	0.00183	0.00186	CcSEcCtD
Gonadorelin—Nausea—Erlotinib—kidney cancer	0.00183	0.00186	CcSEcCtD
Gonadorelin—Diarrhoea—Sunitinib—kidney cancer	0.00182	0.00186	CcSEcCtD
Gonadorelin—Asthenia—Dactinomycin—kidney cancer	0.00181	0.00184	CcSEcCtD
Gonadorelin—Erythema—Capecitabine—kidney cancer	0.0018	0.00183	CcSEcCtD
Gonadorelin—Anaphylactic shock—Paclitaxel—kidney cancer	0.00179	0.00182	CcSEcCtD
Gonadorelin—Abdominal pain—Vincristine—kidney cancer	0.00178	0.00181	CcSEcCtD
Gonadorelin—Flatulence—Capecitabine—kidney cancer	0.00177	0.00181	CcSEcCtD
Gonadorelin—Shock—Paclitaxel—kidney cancer	0.00176	0.00179	CcSEcCtD
Gonadorelin—Vomiting—Sorafenib—kidney cancer	0.00176	0.00179	CcSEcCtD
Gonadorelin—Nervous system disorder—Paclitaxel—kidney cancer	0.00175	0.00179	CcSEcCtD
Gonadorelin—Breast disorder—Doxorubicin—kidney cancer	0.00174	0.00177	CcSEcCtD
Gonadorelin—Headache—Sorafenib—kidney cancer	0.00173	0.00177	CcSEcCtD
Gonadorelin—Diarrhoea—Dactinomycin—kidney cancer	0.00172	0.00176	CcSEcCtD
Gonadorelin—Vomiting—Sunitinib—kidney cancer	0.00169	0.00173	CcSEcCtD
Gonadorelin—Headache—Sunitinib—kidney cancer	0.00167	0.0017	CcSEcCtD
Gonadorelin—Hypersensitivity—Vincristine—kidney cancer	0.00166	0.00169	CcSEcCtD
Gonadorelin—Nausea—Sorafenib—kidney cancer	0.00164	0.00168	CcSEcCtD
Gonadorelin—Asthenia—Vincristine—kidney cancer	0.00162	0.00165	CcSEcCtD
Gonadorelin—Vomiting—Dactinomycin—kidney cancer	0.0016	0.00163	CcSEcCtD
Gonadorelin—Nausea—Sunitinib—kidney cancer	0.00158	0.00161	CcSEcCtD
Gonadorelin—Upper respiratory tract infection—Doxorubicin—kidney cancer	0.00155	0.00158	CcSEcCtD
Gonadorelin—Gastrointestinal disorder—Paclitaxel—kidney cancer	0.00154	0.00157	CcSEcCtD
Gonadorelin—Fatigue—Paclitaxel—kidney cancer	0.00154	0.00157	CcSEcCtD
Gonadorelin—Diarrhoea—Vincristine—kidney cancer	0.00154	0.00157	CcSEcCtD
Gonadorelin—Asthenia—Gemcitabine—kidney cancer	0.00153	0.00156	CcSEcCtD
Gonadorelin—Pain—Paclitaxel—kidney cancer	0.00153	0.00156	CcSEcCtD
Gonadorelin—Constipation—Paclitaxel—kidney cancer	0.00153	0.00156	CcSEcCtD
Gonadorelin—Pruritus—Gemcitabine—kidney cancer	0.00151	0.00154	CcSEcCtD
Gonadorelin—Nausea—Dactinomycin—kidney cancer	0.0015	0.00153	CcSEcCtD
Gonadorelin—Gastrointestinal pain—Paclitaxel—kidney cancer	0.00146	0.00149	CcSEcCtD
Gonadorelin—Diarrhoea—Gemcitabine—kidney cancer	0.00146	0.00149	CcSEcCtD
Gonadorelin—Shock—Capecitabine—kidney cancer	0.00144	0.00147	CcSEcCtD
Gonadorelin—Nervous system disorder—Capecitabine—kidney cancer	0.00144	0.00147	CcSEcCtD
Gonadorelin—Vomiting—Vincristine—kidney cancer	0.00143	0.00146	CcSEcCtD
Gonadorelin—Abdominal pain—Paclitaxel—kidney cancer	0.00141	0.00144	CcSEcCtD
Gonadorelin—Headache—Vincristine—kidney cancer	0.00141	0.00144	CcSEcCtD
Gonadorelin—Vomiting—Gemcitabine—kidney cancer	0.00136	0.00138	CcSEcCtD
Gonadorelin—Headache—Gemcitabine—kidney cancer	0.00134	0.00136	CcSEcCtD
Gonadorelin—Nausea—Vincristine—kidney cancer	0.00134	0.00136	CcSEcCtD
Gonadorelin—Hypersensitivity—Paclitaxel—kidney cancer	0.00132	0.00134	CcSEcCtD
Gonadorelin—Asthenia—Paclitaxel—kidney cancer	0.00128	0.00131	CcSEcCtD
Gonadorelin—Nausea—Gemcitabine—kidney cancer	0.00127	0.00129	CcSEcCtD
Gonadorelin—Gastrointestinal disorder—Capecitabine—kidney cancer	0.00127	0.00129	CcSEcCtD
Gonadorelin—Fatigue—Capecitabine—kidney cancer	0.00126	0.00129	CcSEcCtD
Gonadorelin—Pruritus—Paclitaxel—kidney cancer	0.00126	0.00129	CcSEcCtD
Gonadorelin—Pain—Capecitabine—kidney cancer	0.00125	0.00128	CcSEcCtD
Gonadorelin—Constipation—Capecitabine—kidney cancer	0.00125	0.00128	CcSEcCtD
Gonadorelin—Diarrhoea—Paclitaxel—kidney cancer	0.00122	0.00125	CcSEcCtD
Gonadorelin—Angiopathy—Doxorubicin—kidney cancer	0.00121	0.00123	CcSEcCtD
Gonadorelin—Immune system disorder—Doxorubicin—kidney cancer	0.0012	0.00123	CcSEcCtD
Gonadorelin—Gastrointestinal pain—Capecitabine—kidney cancer	0.0012	0.00122	CcSEcCtD
Gonadorelin—Abdominal pain—Capecitabine—kidney cancer	0.00116	0.00118	CcSEcCtD
Gonadorelin—Erythema—Doxorubicin—kidney cancer	0.00116	0.00118	CcSEcCtD
Gonadorelin—Flatulence—Doxorubicin—kidney cancer	0.00114	0.00116	CcSEcCtD
Gonadorelin—Vomiting—Paclitaxel—kidney cancer	0.00114	0.00116	CcSEcCtD
Gonadorelin—Headache—Paclitaxel—kidney cancer	0.00112	0.00114	CcSEcCtD
Gonadorelin—Hypersensitivity—Capecitabine—kidney cancer	0.00108	0.0011	CcSEcCtD
Gonadorelin—Nausea—Paclitaxel—kidney cancer	0.00106	0.00108	CcSEcCtD
Gonadorelin—Asthenia—Capecitabine—kidney cancer	0.00105	0.00107	CcSEcCtD
Gonadorelin—Pruritus—Capecitabine—kidney cancer	0.00104	0.00106	CcSEcCtD
Gonadorelin—Diarrhoea—Capecitabine—kidney cancer	0.001	0.00102	CcSEcCtD
Gonadorelin—Anaphylactic shock—Doxorubicin—kidney cancer	0.000946	0.000964	CcSEcCtD
Gonadorelin—Vomiting—Capecitabine—kidney cancer	0.000933	0.000951	CcSEcCtD
Gonadorelin—Shock—Doxorubicin—kidney cancer	0.00093	0.000949	CcSEcCtD
Gonadorelin—Nervous system disorder—Doxorubicin—kidney cancer	0.000927	0.000946	CcSEcCtD
Gonadorelin—Headache—Capecitabine—kidney cancer	0.000919	0.000937	CcSEcCtD
Gonadorelin—Nausea—Capecitabine—kidney cancer	0.000872	0.000889	CcSEcCtD
Gonadorelin—Gastrointestinal disorder—Doxorubicin—kidney cancer	0.000817	0.000833	CcSEcCtD
Gonadorelin—Fatigue—Doxorubicin—kidney cancer	0.000815	0.000831	CcSEcCtD
Gonadorelin—Pain—Doxorubicin—kidney cancer	0.000809	0.000825	CcSEcCtD
Gonadorelin—Constipation—Doxorubicin—kidney cancer	0.000809	0.000825	CcSEcCtD
Gonadorelin—Gastrointestinal pain—Doxorubicin—kidney cancer	0.000773	0.000789	CcSEcCtD
Gonadorelin—Abdominal pain—Doxorubicin—kidney cancer	0.000748	0.000762	CcSEcCtD
Gonadorelin—Hypersensitivity—Doxorubicin—kidney cancer	0.000697	0.000711	CcSEcCtD
Gonadorelin—Asthenia—Doxorubicin—kidney cancer	0.000679	0.000692	CcSEcCtD
Gonadorelin—Pruritus—Doxorubicin—kidney cancer	0.000669	0.000682	CcSEcCtD
Gonadorelin—Diarrhoea—Doxorubicin—kidney cancer	0.000647	0.00066	CcSEcCtD
Gonadorelin—Vomiting—Doxorubicin—kidney cancer	0.000601	0.000613	CcSEcCtD
Gonadorelin—Headache—Doxorubicin—kidney cancer	0.000592	0.000604	CcSEcCtD
Gonadorelin—Nausea—Doxorubicin—kidney cancer	0.000562	0.000573	CcSEcCtD
